Bone marrow-targeted liposomal carriers

Bibliography

• Janknegt R, de Marie S, Bakker-Woudenberg IA, Crommelin DJ. Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet 1992;23:279-91
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specificity nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318
   PubMed Web of Science ®Google Scholar
• Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990;268:235-7
   PubMed Web of Science ®Google Scholar
• Awasthi VD, Garcia D, Goins BA, Phillips WT. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm 2003;253:121-32
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60
   PubMed Web of Science ®Google Scholar
• Van Furth R. Development and distribution of mononuclear phagocytes. In: Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York; 1992
   Google Scholar
• Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223-61
   PubMed Web of Science ®Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-16
   PubMed Web of Science ®Google Scholar
• Taylor PR, Martinez-Pomares L, Stacey M, Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901-44
   PubMed Web of Science ®Google Scholar
• Sou K, Goins B, Takeoka S, Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo. Biomaterials 2007;28:2655-66
   PubMed Web of Science ®Google Scholar
• Sou K, Goins B, Leland MM, Bone marrow-targeted liposomal carriers: a feasibility study in nonhuman primates. Nanomedicine 2010;5:41-9
   PubMed Web of Science ®Google Scholar
• Mistry PK, Wraight EP, Cox TM. Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease. Lancet 1996;348:1555-9
   PubMed Web of Science ®Google Scholar
• Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009;106:1261-6
   PubMed Web of Science ®Google Scholar
• Gamazo C, Prior S, Concepcion Lecaroz M, Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections. Expert Opin Drug Deliv 2007;4:677-88
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Release 2008;127:50-8
   PubMed Web of Science ®Google Scholar
• Romero EL, Morilla MJ. Drug delivery systems against leishmaniasis? Still an open question. Expert Opin Drug Deliv 2008;5:805-23
   PubMed Web of Science ®Google Scholar
• Schafer V, von Briesen H, Andreesen R, Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting. Pharm Res 1992;9:541-6
   PubMed Web of Science ®Google Scholar
• Chellat F, Merhi Y, Moreau A, Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005;26:7260-75
   PubMed Web of Science ®Google Scholar
• Kim SS, Ye C, Kumar P, Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 2010;18:993-1001
   PubMed Web of Science ®Google Scholar
• Moreno PR, Falk E, Palacios IF, Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8
   PubMed Web of Science ®Google Scholar
• Wilson HM, Barker RN, Erwig LP. Macrophages: promising targets for the treatment of atherosclerosis. Curr Vasc Pharmacol 2009;7:234-43
   PubMed Web of Science ®Google Scholar
• Antoniades C, Psarros C, Tousoulis D, Nanoparticles: a promising therapeutic approach in atherosclerosis. Curr Drug Deliv 2010;7:303-11
   PubMedGoogle Scholar
• Kawakami S, Sato A, Nishikawa M, Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000;7:292-9
   PubMed Web of Science ®Google Scholar
• Wijagkanalan W, Kawakami S, Takenaga M, Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 2008;125:121-30
   PubMed Web of Science ®Google Scholar
• Matsui M, Shimizu Y, Kodera Y, Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci 2010;101:1670-7
   PubMed Web of Science ®Google Scholar
• Nahar M, Jain NK. Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles. Pharm Res 2009;26:2588-98
   PubMed Web of Science ®Google Scholar
• Mahajan S, Prashant CK, Koul V, Receptor specific macrophage targeting by mannose-conjugated gelatin nanoparticles- an in vitro and in vivo study. Curr Nanosci 2010;6:413-21
   Web of Science ®Google Scholar
• Higuchi Y, Oka M, Kawakami S, Hashida M. Mannosylated semiconductor quantum dots for the labeling of macrophages. J Control Release 2008;125:131-6
   PubMed Web of Science ®Google Scholar
• Kumar PV, Asthana A, Dutta T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 2006;14:546-56
   PubMed Web of Science ®Google Scholar
• Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 2008;5:703-24
   PubMed Web of Science ®Google Scholar
• Wu F, Wuensch SA, Azadniv M, Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses. Mol Pharm 2009;6:1506-17
   PubMed Web of Science ®Google Scholar
• Haensler J, Schuber F. Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochim Biophys Acta 1988;946:95-105
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Baldeschwieler JD, Grubbs RH. Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages. Biochim Biophys Acta 1996;1278:59-67
   PubMed Web of Science ®Google Scholar
• Rensen PC, Gras JC, Lindfors EK, Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A. Curr Drug Discov Technol 2006;3:135-44
   PubMedGoogle Scholar
• Lipinski MJ, Frias JC, Amirbekian V, Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc Imaging 2009;2:637-47
   PubMed Web of Science ®Google Scholar
• Turk MJ, Waters DJ, Low PS. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 2004;213:165-72
   PubMed Web of Science ®Google Scholar
• Xia W, Hilgenbrink AR, Matteson EL, A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009;113:438-46
   PubMed Web of Science ®Google Scholar
• Zhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 2008;5:309-19
   PubMed Web of Science ®Google Scholar
• Fliedner TM, Steinbach KH, Hoelzer D. Adaptation to environmental change: the role of cell-renewal systems. In: Finckh ES, editor, The effects of environment on cells and tissues. Excerpta Medica, Amsterdam; 1976
   Google Scholar
• Fliedner TM, Graessle D, Paulsen C, Reimers K. Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure. Cancer Biother Radiopharm 2002;17:405-26
   PubMed Web of Science ®Google Scholar
• Hussain MM, Mahley RW, Boyles JK, Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem 1989;264:9571-82
   PubMed Web of Science ®Google Scholar
• Hussain MM, Mahley RW, Boyles JK, Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J Biol Chem 1989;264:17931-8
   PubMed Web of Science ®Google Scholar
• Furze RC, Rankin SM. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J 2008;22:3111-19
   PubMed Web of Science ®Google Scholar
• Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008;125:281-8
   PubMed Web of Science ®Google Scholar
• Sadahira Y, Mori M. Role of the macrophage in erythropoiesis. Pathol Int 1999;49:841-8
   PubMed Web of Science ®Google Scholar
• Yoshida H, Kawane K, Koike M, Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 2005;437:754-8
   PubMed Web of Science ®Google Scholar
• Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008;112:470-8
   PubMed Web of Science ®Google Scholar
• Winkler IG, Sims NA, Pettit AR, Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSC. Blood 2010;116:4815-28
   Google Scholar
• Porter CJ, Moghimi SM, Illum L, Davis SS. The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992;305:62-6
   PubMed Web of Science ®Google Scholar
• Schettini DA, Ribeiro RR, Demicheli C, Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size. Int J Pharm 2006;315:140-7
   PubMed Web of Science ®Google Scholar
• Chi B, Park SJ, Park MH, Oligopeptide delivery carrier for osteoclast precursors. Bioconjug Chem 2010;21:1473-8
   PubMed Web of Science ®Google Scholar
• Harris TJ, Green JJ, Fung PW, Tissue-specific gene delivery via nanoparticle coating. Biomaterials 2010;31:998-1006
   PubMed Web of Science ®Google Scholar
• Moghimi SM. Exploiting bone marrow microvascular structure for drug delivery and future therapies. Adv Drug Deliv Rev 1995;17:61-73
   Web of Science ®Google Scholar
• Huang TS. Passage of foreign particles through the sinusoidal wall of the rabbit bone marrow-an electron microscopic study. Acta Pathol Jpn 1971;21:349-67
   PubMedGoogle Scholar
• Allen TM, Austin GA, Chonn A, Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta 1991;1061:56-64
   PubMed Web of Science ®Google Scholar
• Nishikawa K, Arai H, Inoue K. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem 1990;265:5226-31
   PubMed Web of Science ®Google Scholar
• Szabo R, Peiser L, Pluddemann A, Uptake of branched polypeptides with poly[L-lys] backbone by bone-marrow culture-derived murine macrophages: the role of the class A scavenger receptor. Bioconjug Chem 2005;16:1442-50
   PubMed Web of Science ®Google Scholar
• Tokuda H, Masuda S, Takakura Y, Specific uptake of succinylated proteins via a scavenger receptor-mediated mechanism in cultured brain microvessel endothelial cells. Biochem Biophys Res Commun 1993;196:18-24
   PubMed Web of Science ®Google Scholar
• Allen TM, The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 1994;13:285-309
   Web of Science ®Google Scholar
• Tsuchida E. Blood Substitute: present and future perspective. Elsevier Science, Amsterdam; 1998
   Google Scholar
• Tsuchida E, Sou K, Nakagawa A, Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjugate Chem 2009;20:1419-40
   PubMed Web of Science ®Google Scholar
• Sakai H, Sou K, Horinouchi H, Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 2008;263:4-15
   PubMed Web of Science ®Google Scholar
• Sou K, Klipper R, Goins B, Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J Pham Exp Ther 2005;312:702-9
   PubMed Web of Science ®Google Scholar
• Taguchi K, Urata Y, Anraku M, Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier. Drug Metab Dispos 2009;37:1456-63
   PubMed Web of Science ®Google Scholar
• Sakai H, Horinouchi H, Tomiyama K, Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 2001;159:1079-88
   PubMed Web of Science ®Google Scholar
• Uster PS, Allen TM, Daniel BE, Insertion of poly-(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 1996;386:243-6
   PubMed Web of Science ®Google Scholar
• Sou K, Endo T, Takeoka S, Tsuchida E. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjug Chem 2000;11:372-9
   PubMed Web of Science ®Google Scholar
• Sou K, Naito Y, Endo T, Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol Prog 2003;19:1547-52
   PubMed Web of Science ®Google Scholar
• Sato T, Sakai H, Sou K, Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative. J Phys Chem B 2009;113:8418-28
   PubMed Web of Science ®Google Scholar
• Goins B, Phillips WT. The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog Lipid Res 2001;40:95-123
   PubMed Web of Science ®Google Scholar
• Gabizon A, Chisin R, Amselem S, Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer 1991;64:1125-32
   PubMed Web of Science ®Google Scholar
• Laverman P, Brouwers AH, Dams ET, Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther 2000;293:996-1001
   PubMed Web of Science ®Google Scholar
• Phillips WT, Rudolph AS, Goins B, A simple method for producing a technetium-99m labeled liposome which is stable in vivo. Nucl Med Biol 1992;19:539-47
   Web of Science ®Google Scholar
• Morrie E, Kricun MD. Red–yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 1985;14:10-19
   PubMed Web of Science ®Google Scholar
• Oyajobi BO, Munoz S, Kakonen R, Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging. Mol Cancer Ther 2007;6:1701-8
   PubMed Web of Science ®Google Scholar
• Gupta S, Pal A, Vyas SP. Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin Drug Deliv 2010;7:371-402
   PubMed Web of Science ®Google Scholar
• Boitano AE, Wang J, Romeo R, Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010;329:1345-8
   PubMed Web of Science ®Google Scholar
• Langer R. Drug delivery and targeting. Nature 1998;392:5-10
   PubMed Web of Science ®Google Scholar
• Legendre JY, Szoka FC. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm Res 1992;9:1235-42
   PubMed Web of Science ®Google Scholar
• Obata Y, Tajima S, Takeoka S. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. J Control Release 2010;142:267-76
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197-201
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005;44:68-97
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-70
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Macrophage polarization: tumor-assosiated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-55
   PubMed Web of Science ®Google Scholar
• Dove A. Cell-based therapies go live. Nature Biotechnol 2002;20:339-43
   PubMed Web of Science ®Google Scholar
• Burke B, Sumner S, Maitland N, Lewis CE. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol 2002;72:417-28
   PubMed Web of Science ®Google Scholar
• Hinds KA, Hill JM, Shapiro EM, Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003;102:867-72
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-64
   PubMed Web of Science ®Google Scholar